Literature DB >> 21442174

Circulating levels of the adipocytokines vaspin and omentin in patients with Kawasaki disease.

Antonella Fioravanti, Gabriele Simonini, Luca Cantarini, Marta Generoso, Mauro Galeazzi, Maria Romana Bacarelli, Rolando Cimaz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21442174     DOI： 10.1007/s00296-011-1873-3

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


× No keyword cloud information.
  10 in total

1.  Vaspin and omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis.

Authors:  Ladislav Senolt; Markéta Polanská; Maria Filková; Lucie Andrés Cerezo; Karel Pavelka; Steffen Gay; Martin Haluzík; Jirí Vencovsky
Journal:  Ann Rheum Dis       Date:  2009-11-12       Impact factor: 19.103

2.  Circulating adiponectin levels in Kawasaki disease.

Authors:  Seiichiro Takeshita; Humiyo Takabayashi; Naoki Yoshida
Journal:  Acta Paediatr       Date:  2006-10       Impact factor: 2.299

3.  Omentin plasma levels and gene expression are decreased in obesity.

Authors:  Celia M de Souza Batista; Rong-Ze Yang; Mi-Jeong Lee; Nicole M Glynn; Dao-Zhan Yu; Jessica Pray; Kelechi Ndubuizu; Susheel Patil; Alan Schwartz; Mark Kligman; Susan K Fried; Da-Wei Gong; Alan R Shuldiner; Toni I Pollin; John C McLenithan
Journal:  Diabetes       Date:  2007-02-28       Impact factor: 9.461

4.  Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin.

Authors:  N Ouchi; S Kihara; Y Arita; K Maeda; H Kuriyama; Y Okamoto; K Hotta; M Nishida; M Takahashi; T Nakamura; S Yamashita; T Funahashi; Y Matsuzawa
Journal:  Circulation       Date:  1999 Dec 21-28       Impact factor: 29.690

5.  Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity.

Authors:  Kazuyuki Hida; Jun Wada; Jun Eguchi; Hong Zhang; Masako Baba; Aya Seida; Izumi Hashimoto; Tatsuo Okada; Akihiro Yasuhara; Atsuko Nakatsuka; Kenichi Shikata; Shinji Hourai; Junichiro Futami; Eijiro Watanabe; Yasushi Matsuki; Ryuji Hiramatsu; Shigeru Akagi; Hirofumi Makino; Yashpal S Kanwar
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-19       Impact factor: 11.205

6.  Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert
Journal:  Pediatrics       Date:  2004-12       Impact factor: 7.124

Review 7.  Adipokines as emerging mediators of immune response and inflammation.

Authors:  Francisca Lago; Carlos Dieguez; Juan Gómez-Reino; Oreste Gualillo
Journal:  Nat Clin Pract Rheumatol       Date:  2007-12

8.  Novel and traditional cardiovascular risk factors in children after Kawasaki disease: implications for premature atherosclerosis.

Authors:  Yiu-fai Cheung; Tak-cheung Yung; Sidney C F Tam; Marco H K Ho; Adolphus K T Chau
Journal:  J Am Coll Cardiol       Date:  2004-01-07       Impact factor: 24.094

Review 9.  Kawasaki syndrome.

Authors:  Jane C Burns; Mary P Glodé
Journal:  Lancet       Date:  2004 Aug 7-13       Impact factor: 79.321

10.  Frequency and significance of the novel single nucleotide missense polymorphism Val109Asp in the human gene encoding omentin in Caucasian patients with type 2 diabetes mellitus or chronic inflammatory bowel diseases.

Authors:  Andreas Schäffler; Martina Zeitoun; Hella Wobser; Christa Buechler; Charalampos Aslanidis; Hans Herfarth
Journal:  Cardiovasc Diabetol       Date:  2007-02-13       Impact factor: 9.951
  10 in total
  5 in total

1.  High serum vaspin concentrations in patients with ulcerative colitis.

Authors:  Tomohito Morisaki; Fuminao Takeshima; Hiroko Fukuda; Kayoko Matsushima; Yuko Akazawa; Naoyuki Yamaguchi; Ken Ohnita; Hajime Isomoto; Hiroaki Takeshita; Terumitsu Sawai; Fumihiko Fujita; Kazuhiko Nakao
Journal:  Dig Dis Sci       Date:  2013-10-29       Impact factor: 3.199

2.  [Changes in serum levels of adipokine after treatment in children with Kawasaki disease].

Authors:  Hong Xiang; Ming Chang; Qiu-Xia Wang; Hong-Yan Lu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-01

3.  Circulating adipokines are associated with Kawasaki disease.

Authors:  Xin-Yan Zhang; Ting-Ting Yang; Xiu-Fen Hu; Yu Wen; Feng Fang; Hui-Ling Lu
Journal:  Pediatr Rheumatol Online J       Date:  2018-05-08       Impact factor: 3.054

4.  Cardioprotective properties of omentin-1 in type 2 diabetes: evidence from clinical and in vitro studies.

Authors:  Sabrina Greulich; Weena J Y Chen; Bujar Maxhera; Luuk J Rijzewijk; Rutger W van der Meer; Jacqueline T Jonker; Heidi Mueller; Daniella Herzfeld de Wiza; Ralf-Ruediger Floerke; Konstantinos Smiris; Hildo J Lamb; Albert de Roos; Jeroen J Bax; Johannes A Romijn; Jan W A Smit; Payam Akhyari; Artur Lichtenberg; Juergen Eckel; Michaela Diamant; D Margriet Ouwens
Journal:  PLoS One       Date:  2013-03-29       Impact factor: 3.240

5.  Association between intelectin-1 variation and human kidney stone disease in northeastern Thai population.

Authors:  Thanakorn Pungsrinont; Choochai Nettuwakul; Nunghathai Sawasdee; Nanyawan Rungroj; Suchai Sritippayawan; Pa-Thai Yenchitsomanus
Journal:  Urolithiasis       Date:  2021-05-26       Impact factor: 3.436
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.